A federal judge in Manhattan has sharply narrowed one of the most closely watched criminal cases in the country, ruling that prosecutors cannot pursue the death penalty against Luigi Mangione in connection with the killing of UnitedHealthcare CEO Brian Thompson. Judge Margaret Garnett of the U.S. District Court for the Southern District of New York dismissed the murder count that exposed Mangione to capital punishment, while allowing stalking charges to remain in place.

The ruling is significant not only because of the profile of the alleged victim and the public attention surrounding the case, but also because it underscores the limits of federal charging authority in capital cases.

Another publisher has joined the fast-growing line of plaintiffs testing how copyright law applies to generative AI. U.S. News World Report has sued OpenAI in the Southern District of New York, alleging the company used its content without authorization to train AI models and generate outputs that compete with or diminish the value of the publisher’s work. The case, U.S. News World Report, L.P. v. OpenAI, Inc. et al, adds another closely watched dispute to a litigation trend that is rapidly becoming one of the most consequential battles in technology and media law.

At a high level, these cases raise a core question: when AI developers ingest large volumes of copyrighted material to train models, does that qualify as lawful fair use, or does it require permission and compensation? Publishers bringing these suits generally argue that model training and AI-generated summaries or reproductions exploit protected expression and threaten traffic, subscriptions, and licensing markets.

The Department of Justice’s Antitrust Division, alongside the U.S. Attorney’s Office for the Southern District of New York, has filed a civil antitrust suit against New York-Presbyterian, alleging the hospital system used contractual restrictions that limited access to lower-cost healthcare options. The case, United States Of America v. New York Presbyterian Hospital, is an important marker of where federal healthcare enforcement appears to be headed: closer scrutiny of contract terms that may steer patients away from cheaper alternatives and preserve market power for dominant providers.

According to the government, the challenged restrictions allegedly prevented health plans from offering or promoting more affordable options that would exclude or limit New York-Presbyterian’s participation.

The U.S. Department of Justice Antitrust Division, joined by the U.S. Attorney’s Office for the Southern District of New York, has filed a civil antitrust case against The New York and Presbyterian Hospital, alleging the hospital used contractual restrictions that limited insurers’ ability to steer patients to lower-cost providers.

The case, United States Of America v. New York Presbyterian Hospital, is one to watch for healthcare providers, payors, and counsel advising on managed care contracting.

A federal judge in Manhattan has dealt a significant blow to the government’s strategy in the prosecution of Luigi Mangione, ruling that prosecutors cannot pursue the death penalty in the killing of UnitedHealthcare CEO Brian Thompson. The decision came by dismissing the federal murder count that opened the door to capital punishment, while allowing stalking charges to remain in place.

That distinction matters.

The antitrust challenge to Live Nation and Ticketmaster remains one of the most closely watched business cases in the country, even as reports indicate the U.S. Department of Justice reached a tentative settlement with the company in March 2026. The reason is straightforward: a broad coalition of states is still pressing forward, ensuring that the litigation continues to shape how courts, regulators, and the live-entertainment industry think about market power, vertical integration, and consumer harm.

The case, pending in the Southern District of New York as United States of America et al v. Live Nation Entertainment, Inc. et al, targets practices that have long drawn criticism from artists, venues, fans, and policymakers: ticketing fees, exclusive venue arrangements, and the combined influence that comes from operating both ticketing platforms and concert promotion businesses.